Home / Import refusals / AEK-8221396-6/11/1

AEK-8221396-6/11/1

AbbVie Inc. — FEI 3009751352

Recent inspections

  • 1277010 (NAI Thu Aug 21 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1257605 (NAI Thu Jun 12 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1231413 (NAI Fri Apr 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1198013 (VAI Tue Jan 31 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1191165 (NAI Thu Oct 06 2022 00:00:00 GMT+0000 (Coordinated Universal Time))

Other import refusals

  • SCS-9968726-6/20003/1 (Wed Jan 21 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Devices)
  • 799-9161571-9/10001/1 (Sun Dec 14 2025 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 799-8712399-1/10001/1 (Fri Dec 12 2025 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 799-7803787-9/10001/1 (Tue Nov 25 2025 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • SCS-5627431-4/20002/1 (Thu Nov 13 2025 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)

Refusal Details

Date
March 4, 2025
Country
United States
Product Category
Drugs and Biologics
Product Code
58MCY09 RISANKIZUMAB-RZAA
Charges
75